Dr. Marco Infante

Linkedin
Menu

Pubblicazioni – Dr. Marco Infante

Lista delle pubblicazioni scientifiche del Dr. Marco Infante (aggiornata al 18/11/2024)

 

h-index: 22 (Google Scholar), 18 (Scopus); dato aggiornato al 18/11/2024

Citazioni totali: 2198 (Google Scholar), 1336 (Scopus); dato aggiornato al 18/11/2024 

 

Pubblicazioni su Riviste Scientifiche Internazionali “Peer-Reviewed”

  • Caprio M, Infante M, Calanchini M, Mammi C, Fabbri A. Vitamin D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects. Eat Weight Disord. 2017 Mar;22(1):27-41. DOI: 10.1007/s40519-016-0312-6. Epub 2016 Aug 23. PMID: 27553017. 
  • Infante M, Armani A, Mammi C, Fabbri A, Caprio M. Impact of Adrenal Steroids on Regulation of Adipose Tissue. Compr Physiol. 2017 Sep 12;7(4):1425-1447. DOI: 10.1002/cphy.c160037. PMID: 28915330.
  • Infante M, Caprio M, Fabbri A (2017). Regulation of adipose tissue function and metabolism: role of mineralocorticoid receptor. Official Journal of the International Union of Aesthetic Medicine – UIME, ISSN 2421-7115 (vol. 3, nr. 4, October/December 2017).
  • Infante M, Corradini D, Romano M, Bellia A, Lauro D. Life-threatening hypocalcemia in a patient with highly suspected osteomalacia: a case report. AACE Clinical Case Reports. 2018; volume 4, issue 2, pages 174-178. DOI: 10.4158/EP171982.CR.
  • Infante M, Sears B, Rizzo AM, Mariani Cerati D, Caprio M, Ricordi C, Fabbri A. Omega-3 PUFAs and vitamin D co-supplementation as a safe-effective therapeutic approach for core symptoms of autism spectrum disorder: case report and literature review. Nutr Neurosci. 2020 Oct;23(10):779-790. DOI: 10.1080/1028415X.2018.1557385. Epub 2018 Dec 13. PMID: 30545280.
  • Izzo V, Greco C, Corradini D, Infante M, Staltari MT, Romano M, Bellia A, Lauro D, Uccioli L. Insulin autoimmune syndrome in an Argentine woman taking α-lipoic acid: A case report and review of the literature. SAGE Open Med Case Rep. 2018 Dec 26;6:2050313X18819601. DOI: 10.1177/2050313X18819601. PMID: 30627435. PMCID: PMC6311546.
  • Infante M, Fabi A, Cognetti F, Gorini S, Caprio M, Fabbri A. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives. J Exp Clin Cancer Res. 2019 Jan 8;38(1):12. DOI: 10.1186/s13046-018-1001-2. PMID: 30621730. PMCID: PMC6325760.
  • Infante M, Armani A, Marzolla V, Fabbri A, Caprio M. Adipocyte Mineralocorticoid Receptor. Vitam Horm. 2019;109:189-209. DOI: 10.1016/bs.vh.2018.10.005. Epub 2018 Dec 21. PMID: 30678856.
  • Infante M, Ricordi C, Baidal DA, Alejandro R, Lanzoni G, Sears B, Caprio M, Fabbri A. VITAL study: an incomplete picture? Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):3142-3147. DOI: 10.26355/eurrev_201904_17599. PMID: 31002167.
  • Armani A, Infante M, Fabbri A, Caprio M (2019). Comment on “mineralocorticoid antagonism enhances brown adipose tissue function in humans: A randomized placebo‐controlled cross‐over study” Diabetes Obes Metab. 2019; 21: 2024-2026. DOI: 10.1111/dom.13756. PMID: 31050122. 
  1. Caprio M, Moriconi E, Infante M, De Martino MU, Aversa A. PS-05-003 The role of nutritional intervention in the treatment of male hypogonadism secondary to obesity (Conference abstract at the 21st Congress of the European Society for Sexual Medicine; 14-16 February 2019, Ljubljana, Slovenia). The Journal of Sexual Medicine. May 2019 Volume 16, Issue 5, Supplement 2, Page S14. DOI: 10.1016/j.jsxm.2019.03.072.
  2. Caprio M, Infante M, Moriconi E, Armani A, Fabbri A, Mantovani G, et al., on behalf of the Cardiovascular Endocrinology Club of the Italian Society of Endocrinology. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). J Endocrinol Invest. 2019 Nov;42(11):1365-1386. DOI: 10.1007/s40618-019-01061-2. PMID: 31111407.
  3. Gorini S, Kim SK, Infante M, Mammi C, La Vignera S, Fabbri A, Jaffe IZ, Caprio M. Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging. Front Endocrinol (Lausanne). 2019 Aug 23;10:584. DOI: 10.3389/fendo.2019.00584. PMID: 31507534. PMCID: PMC6716354.
  4. Ricordi C, Clare-Salzler M, Infante M, Baggerly C, Aliano J, McDonnell S, Chritton S. Vitamin D and Omega 3 Field Study on Progression of Type 1 Diabetes. CellR4 Repair Replace Regen Reprogram. 2019;7. pii: e2737. DOI: 10.32113/cellr4_20198_2737. PMID: 31572748. PMCID: PMC6768421.
  5. Infante M, Ricordi C, Sanchez J, Clare-Salzler MJ, Padilla N, Fuenmayor V, Chavez C, Alvarez A, Baidal D, Alejandro R, Caprio M, Fabbri A. Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes. Nutrients. 2019 Sep 11;11(9). pii: E2185. DOI: 10.3390/nu11092185. PMID: 31514368. PMCID: PMC6769474.
  6. Simonetto M*, Infante M*, Sacco RL, Rundek T, Della-Morte D. A Novel Anti-Inflammatory Role of Omega-3 PUFAs in Prevention and Treatment of Atherosclerosis and Vascular Cognitive Impairment and Dementia. Nutrients. 2019 Sep 23;11(10). pii: E2279. DOI: 10.3390/nu11102279. PMID: 31547601. PMCID: PMC6835717. *Equal contribution to the manuscript.
  7. Infante M, Ricordi C. Editorial – Moving forward on the pathway of targeted immunotherapies for type 1 diabetes: the importance of disease heterogeneity. Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8702-8704. DOI: 10.26355/eurrev_201910_19188. PMID: 31646605.
  8. Infante M, Della-Morte D. Diabetes and cognitive dysfunction: a dangerous liaison. CellR4 2019; 7: e2776. DOI: 10.32113/cellr4_201910_2776.
  9. Infante M, Ricordi C, Padilla N, Alvarez A, Linetsky E, Lanzoni G, Mattina A, Bertuzzi F, Fabbri A, Baidal D, Alejandro R. The Role of Vitamin D and Omega-3 PUFAs in Islet Transplantation. Nutrients. 2019 Dec 3;11(12). pii: E2937. DOI: 10.3390/nu11122937. PMID: 31816979. PMCID: PMC6950335.
  10. Fabbri A, Infante M, Ricordi C. Editorial – Vitamin D Status: A Key Modulator of Innate Immunity and Natural Defense From Acute Viral Respiratory Infections. Eur Rev Med Pharmacol Sci 2020 Apr;24(7):4048-4052. DOI: 10.26355/eurrev_202004_20876. PMID: 32329882. 
  11. Infante M, Ricordi C, Fabbri A. Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic. J Diabetes. 2020;12(9):659-667. DOI: 10.1111/1753-0407.13053. PMID: 32401405. PMCID: PMC7272905.
  12. Infante M, Ricordi C, Alejandro R, Caprio M, Fabbri A. Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection. Expert Rev Anti Infect Ther. 2021 Jan;19(1):5-16. Epub 2020 Aug 16. DOI: 10.1080/14787210.2020.1799785. PMID: 32693652. PMCID: PMC7441799.
  13. Moriconi E, Feraco A, Marzolla V, Infante M, Lombardo M, Fabbri A, Caprio M. Neuroendocrine and Metabolic Effects of Low-Calorie and Non-Calorie Sweeteners. Front Endocrinol (Lausanne). 2020 Jul 16; 11:444. DOI: 10.3389/fendo.2020.00444. PMID: 32765425. PMCID: PMC7378387.
  14. Maia Pinheiro M, Moura Maia Pinheiro F, Pires Amaral Resende LL, Nogueira Diniz S, Fabbri A, Infante M. Improvement of pure sensory mononeuritis multiplex and IgG1 deficiency with sitagliptin plus Vitamin D3. Eur Rev Med Pharmacol Sci. 2020;24(15):8151-8159. DOI: 10.26355/eurrev_202008_22502. PMID: 32767343.
  15. Gunawardana SC, Infante M. Brown adipose tissue transplantation as a promising approach for insulin-independent reversal of type 1 diabetes: animal studies and clinical perspectives. CellR4 2020; 8: e2986. DOI: 10.32113/cellr4_202012_2986.
  16. Maia Pinheiro M, Maia Pinheiro FM, Amaral Resende LLP, Diniz SN, Fabbri A, Infante M. 36-month follow-up of a pure sensory mononeuritis multiplex and IgG1 deficiency improved after treatment with sitagliptin and Vitamin D3. Eur Rev Med Pharmacol Sci. 2021 Feb;25(4):1768-1769. DOI: 10.26355/eurrev_202102_25064. PMID: 33660837.
  17. Infante M*, Buoso A, Pieri M, Lupisella S, Nuccetelli M, Bernardini S, Fabbri A, Iannetta M, Andreoni M, Colizzi V, Morello M*. Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study. J Am Nutr Assoc. 2022 Mar-Apr;41(3):250-265. DOI: 10.1080/07315724.2021.1877580. Epub 2021 Feb 18. PMID: 33600292; PMCID: PMC7899172. *Equal contribution to the manuscript.
  18. Pinheiro MM, Pinheiro FMM, Diniz SN, Fabbri A, Infante M. Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes. Int Immunopharmacol. 2021 Jun;95:107518. DOI: 10.1016/j.intimp.2021.107518. Epub 2021 Mar 20. PMID: 33756226.
  19. Pinheiro MM, Fabbri A, Infante M. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i). Immunotherapy. 2021 Jun;13(9):753-765. DOI: 10.2217/imt-2020-0349. Epub 2021 Apr 28. PMID: 33906375; PMCID: PMC8080872. 
  20. D’Avolio A, Isaia G, on behalf of COVID-Vitamin D Study Group [Infante M, et al.], Accademia di Medicina di Torino. Vitamin D in the COVID-19 prevention and treatment: emerging evidence. Pharmadvances. Volume 3, Issue 2, 2021 June: 350-6. DOI: 10.36118/pharmadvances.2021.01.   
  21. Infante M, Baidal DA, Rickels MR, Fabbri A, Skyler JS, Alejandro R, Ricordi C. Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions. Artif Organs. 2021 Sep;45(9):968-986. DOI: 10.1111/aor.14023. Epub 2021 Jul 15. PMID: 34263961; PMCID: PMC9059950.
  22. Infante M, Leoni M, Caprio M, Fabbri A. Long-term metformin therapy and vitamin B12 deficiency: An association to bear in mind. World J Diabetes. 2021 Jul 15;12(7):916-931. DOI: 10.4239/wjd.v12.i7.916. PMID: 34326945. PMCID: PMC8311483.
  23. Velikova T, Fabbri A, Infante M. The role of vitamin D as a potential adjuvant for COVID-19 vaccines. Eur Rev Med Pharmacol Sci. 2021 Sep;25(17):5323-5327. DOI: 10.26355/eurrev_202109_26637. PMID: 34533808.
  24. Infante M*, Pieri M, Lupisella S, D’Amore L, Bernardini S, Fabbri A, Iannetta M, Andreoni M, Morello M*. Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19. Eur Rev Med Pharmacol Sci. 2021 Oct;25(19):5889-5903. DOI: 10.26355/eurrev_202110_26865. PMID: 34661247. *Equal contribution to the manuscript. Author Correction: Infante M, Pieri M, Lupisella S, D’Amore L, Bernardini S, Fabbri A, Iannetta M, Andreoni M, Morello M. Author Correction: Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19. Eur Rev Med Pharmacol Sci. 2023 Dec;27(24):11672. DOI: 10.26355/eurrev_202312_34763. PMID: 38164830.
  25. Rios P, Baidal D, Lemos J, Camhi SS, Infante M, Padilla N, Alvarez Gil AM, Fuenmayor V, Ambut J, Qasmi FA, Mantero AM, Cayetano SM, Ruiz P, Ricordi C, Alejandro R. Long-term Persistence of Allosensitization After Islet Allograft Failure. Transplantation. 2021 Nov 1;105(11):2490-2498. DOI: 10.1097/TP.0000000000003635. PMID: 33481552. PMCID: PMC8289921.
  26. Pastore D, Deja-Simoni A, De Stefano A, Pacifici F, Cela E, Infante M, Coppola A, Di Daniele N, Lauro D, Della-Morte D, Donadel G. Risk factors for diabetic foot ulcers: an Albanian retrospective study of inpatients with type 2 diabetes. Eur Rev Med Pharmacol Sci. 2022 Jan;26(2):558-572. DOI: 10.26355/eurrev_202201_27883. PMID: 35113432.
  27. Infante M, Padilla N, Alejandro R, Caprio M, Della-Morte D, Fabbri A, Ricordi C. Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents. Medicina (Kaunas). 2022 Apr 21;58(5):571. DOI: 10.3390/medicina58050571. PMID: 35629988. 
  28. Infante M, Di Perna P, Passeri M, Monetta R, Papola F, Brancati F, Caprio M, Fabbri A. 204-LB: An Unusual Case of Autoantibody-Negative Ketosis-Prone Diabetes (KPD) Secondary to Marked Insulin Resistance. Diabetes 2022;71(Supplement_1):204-LB (June 1, 2022). DOI: 10.2337/db22-204-LB.
  29. Infante M, Fabbri A, Padilla N, Pacifici F, Di Perna P, Vitiello L, Feraco A, Giuliano M, Passeri M, Caprio M, Ricordi C, Della-Morte D, Uccioli L. BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report. Vaccines (Basel). 2022 Jul 8;10(7):1096. DOI: 10.3390/vaccines10071096. PMID: 35891261. 
  30. Silvestri F*, Infante M*, Fabbri A, Ferrara C, Ferraguti G, Costantino F, Ferrari E, Bonci E, Turchetti A, Tiberti C, Tromba V. Skeletal status in children and adolescents with new-onset type 1 diabetes: a preliminary study based on bone densitometry and quantitative ultrasound. Pediatr Endocrinol Diabetes Metab. 2022;28(3):197-206. DOI: 10.5114/pedm.2022.118317. PMID: 36134673. *Equal contribution to the manuscript. 
  31. Marzolla V, Infante M, Armani A, Rizzo M, Caprio M. Efficacy and safety of finerenone for treatment of diabetic kidney disease: current knowledge and future perspective. Expert Opin Drug Saf. 2022 Sep;21(9):1161-1170. DOI: 10.1080/14740338.2022.2130889. Epub 2022 Oct 6. PMID: 36174659.
  32. Infante M, Fabbri A, Della-Morte D, Ricordi C. The importance of vitamin D and omega-3 PUFA supplementation: a nonpharmacologic immunomodulation strategy to halt autoimmunity. Eur Rev Med Pharmacol Sci. 2022 Sep;26(18):6787-6795. DOI: 10.26355/eurrev_202209_29780. PMID: 36196727.
  33. Infante M, Ricordi C. The unique pathophysiological features of diabetes mellitus secondary to total pancreatectomy: proposal for a new classification distinct from diabetes of the exocrine pancreas. Expert Rev Endocrinol Metab. 2023 Jan;18(1):19-32. DOI: 10.1080/17446651.2023.2168645. Epub 2023 Jan 24. PMID: 36692892. 
  34. Infante M*, Pieri M, Lupisella S, Mohamad A, Bernardini S, Della-Morte D, Fabbri A, De Stefano A, Iannetta M, Ansaldo L, Crea A, Andreoni M, Morello M*. Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19. Curr Med Res Opin. 2023 Apr;39(4):505-516. DOI: 10.1080/03007995.2023.2177380. Epub 2023 Feb 22. PMID: 36749566. *Equal contribution to the manuscript. 
  35. D’Alessandro A, Ciavardelli D, Pastore A, Lupisella S, Cristofaro RC, Di Felice G, Salierno R, Infante M, De Stefano A, Onetti Muda A, Morello M, Porzio O. Contribution of vitamin D3 and thiols status to the outcome of COVID-19 disease in Italian pediatric and adult patients. Sci Rep. 2023 Feb 13;13(1):2504. DOI: 10.1038/s41598-023-29519-7. Erratum in: Sci Rep. 2023 Mar 16;13(1):4378. PMID: 36781931; PMCID: PMC9925220. Author Correction: D’Alessandro A, Ciavardelli D, Pastore A, Lupisella S, Cristofaro RC, Di Felice G, Salierno R, Infante M, De Stefano A, Onetti Muda A, Morello M, Porzio O. Author Correction: Contribution of vitamin D3 and thiols status to the outcome of COVID-19 disease in Italian pediatric and adult patients. Sci Rep. 2023 Mar 16;13(1):4378. DOI: 10.1038/s41598-023-31323-2. Erratum for: Sci Rep. 2023 Feb 13;13(1):2504. PMID: 36928368; PMCID: PMC10019380.
  36. Pacifici F, Malatesta G, Mammi C, Pastore D, Marzolla V, Ricordi C, Chiereghin F, Infante M, Donadel G, Curcio F, Noce A, Rovella V, Lauro D, Tesauro M, Di Daniele N, Garaci E, Caprio M, Della-Morte D. A Novel Mix of Polyphenols and Micronutrients Reduces Adipogenesis and Promotes White Adipose Tissue Browning via UCP1 Expression and AMPK Activation. Cells. 2023 Feb 24;12(5):714. DOI: 10.3390/cells12050714. PMID: 36899850.
  37. Bellucci E, Chiereghin F, Pacifici F, Donadel G, De Stefano A, Malatesta G, Valente MG, Guadagni F, Infante M, Rovella V, Noce A, Tesauro M, Di Daniele N, Della Morte D, Pastore D. Novel therapeutic approaches based on the pathological role of gut dysbiosis on the link between nonalcoholic fatty liver disease and insulin resistance. Eur Rev Med Pharmacol Sci. 2023 Mar;27(5):1921-1944. DOI: 10.26355/eurrev_202303_31558. PMID: 36930488.
  38. Pinheiro MM, Pinheiro FMM, de Arruda MM, Beato GM, Verde GACL, Bianchini G, Casalenuovo PRM, Argolo AAA, de Souza LT, Pessoa FG, Hirose TS, Senra EF, Ricordi C, Fabbri A, Infante M, Diniz SN. Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study. Arch Endocrinol Metab. 2023 May 25;67(5):e000652. DOI: 10.20945/2359-3997000000652. PMID: 37249465.
  39. Boccuzzi L*, Infante M*, Ricordi C. The potential therapeutic role of vitamin D in inflammatory bowel disease. Eur Rev Med Pharmacol Sci. 2023 May;27(10):4678-4687. DOI: 10.26355/eurrev_202305_32479. PMID: 37259751. *Equal contribution to the manuscript.
  40. Della-Morte D, Ambrosi C, Chiereghin F, Infante M, Pastore D, Pacifici F, Scaramella M, Gentile L, Mulas F, Quintavalle G. Methods for inactivation of seafood Anisakis larvae and prevention of human anisakiasis: a mini-review. Eur Rev Med Pharmacol Sci. 2023 Jun;27(11):5246-5256. DOI: 10.26355/eurrev_202306_32643. PMID: 37318499.
  41. Infante M, Vitiello L, Fabbri A, Ricordi C, Padilla N, Pacifici F, Perna PD, Passeri M, Della-Morte D, Caprio M, Uccioli L. Prolonged clinical remission of type 1 diabetes sustained by calcifediol and low-dose basal insulin: a case report. Immunotherapy. 2023 Sep;15(13):1009-1019. DOI: 10.2217/imt-2022-0266. Epub 2023 Jul 4. PMID: 37401348.
  42. Padilla N, Fabbri A, Della-Morte D, Ricordi C, Infante M. Immunomodulatory role of vitamin D and omega-3 polyunsaturated fatty acids in autoimmune disorders: Literature Review [Article in Spanish – Title in Spanish: Papel inmunomodulador de la vitamina D y los ácidos grasos poliinsaturados omega-3 en trastornos autoinmunes: Revisión de la Literatura]. Archivos Latinoamericanos de Nutrición 2023; 73(3): 223-232. DOI: 10.37527/2023.73.3.006. 
  43. Morieri ML, Candido R, Frontoni S, Disoteo O, Solini A, Fadini GP; PIONEERING EXPERIENCE study group (Members of the PIONEERING EXPERIENCE study group: Infante M, et al.). Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care. Diabetes Ther. 2023 Dec;14(12):2159-2172. DOI: 10.1007/s13300-023-01490-6. Epub 2023 Oct 18. PMID: 37848758; PMCID: PMC10597935.
  44. Infante R*, Infante M*, Pastore D, Pacifici F, Chiereghin F, Malatesta G, Donadel G, Tesauro M, Della-Morte D. An Appraisal of the Oleocanthal-Rich Extra Virgin Olive Oil (EVOO) and Its Potential Anticancer and Neuroprotective Properties. Int J Mol Sci. 2023 Dec 10;24(24):17323. DOI: 10.3390/ijms242417323. PMID: 38139152; PMCID: PMC10744258. *Equal contribution to the manuscript.
  45. Pinheiro MM, Pinheiro FMM, Garo ML, Pastore D, Pacifici F, Ricordi C, Della-Morte D, Infante M. Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways. Metab Target Organ Damage. 2024; 4(3): 19. DOI: 10.20517/mtod.2024.12. 
  46. Ghadieh HE, Infante M, Sponton CH. Editorial: Mechanistic and physiological implications of insulin resistance in metabolic diseases. Front Endocrinol (Lausanne). 2024 Jul 3;15:1446492. DOI: 10.3389/fendo.2024.1446492. PMID: 39027481; PMCID: PMC11255604.
  47. Pinheiro MM, de Souza LG, Nunes GP, Martin IF, de Oliveira YU, Pinheiro FMM, Costa LN, Caprio M, Della-Morte D, Infante M. The first report of leukocytoclastic vasculitis induced by once-weekly subcutaneous semaglutide. Curr Med Res Opin. 2024 Aug 2:1-7. DOI: 10.1080/03007995.2024.2386047. Epub ahead of print. PMID: 39072425.
  48. Pacifici F, Chiereghin F, D’Orazio M, Malatesta G, Infante M, Fazio F, Bertinato C, Donadel G, Martinelli E, De Lorenzo A, Della-Morte D, Pastore D. Patch-Based Far-Infrared Radiation (FIR) Therapy Does Not Impact Cell Tracking or Motility of Human Melanoma Cells In Vitro. Curr Issues Mol Biol. 2024 Sep 11;46(9):10026-10037. DOI: 10.3390/cimb46090599. PMID: 39329951; PMCID: PMC11429816. 
  49. Trestini I, Belluomini L, Dodi A, Sposito M, Caldart A, Kadrija D, Pasqualin L, Riva ST, Scaglione IM, Tregnago D, Avancini A, Insolda J, Confortini L, Casali M, Menis J, Vita E, Cintoni M, Todesco M, Milanese G, Sperduti I, D’Onofrio M, Infante M, Tiseo M, Mele MC, Tortora G, Milella M, Bria E, Pilotto S. Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study. J Cachexia Sarcopenia Muscle. 2024 Oct 22. DOI: 10.1002/jcsm.13568. Epub ahead of print. PMID: 39439222.

 

Contributi in Volume (Capitoli o Saggi)

  1. Andrea Fabbri, Marco Infante, Massimiliano Caprio. Manuale di Endocrinologia Geriatrica, SICS editore (2017). Editors: Maurizio Gasperi, Antonio Aversa. Chapter 13 – Osteoporosi. ISBN-13: 978-8890685293.
  2. Massimiliano Caprio, Marco Infante, Andrea Fabbri. Manuale di Endocrinologia Geriatrica, SICS editore (2017). Editors: Maurizio Gasperi, Antonio Aversa.  Chapter 16 – Invecchiamento vascolare e sistema mineralcorticoide. ISBN-13: 978-8890685293. 
  3. Marco Infante, Andrea Armani, Vincenzo Marzolla, Andrea Fabbri, Massimiliano Caprio. Aldosterone, Volume 109, 1st Edition, Vitamins and Hormones series by Elsevier, Series Editor: Gerald Litwack (January 2019). Chapter 8 – Adipocyte Mineralocorticoid Receptor. DOI: 10.1016/bs.vh.2018.10.005. ISBN: 9780128177822.
  4. Andrea Armani, Vincenzo Marzolla, Alessandra Feraco, Stefania Gorini, Caterina Mammi, Marco Infante and Massimiliano Caprio. Aldosterone-Mineralocorticoid Receptor – Cell Biology to Translational Medicine (IntechOpen publisher, September 2019). Editors: Brian Harvey and Frederic Jaisser. Chapter 8 – Mineralocorticoid Receptor in Novel Target Tissues: A Closer Look at the Adipocyte. DOI: 10.5772/intechopen.87231. ISBN: 978-1-83962-198-7.
  5. Marco Infante, Nathalia Padilla, Srigita Madiraju, Ana Alvarez, David Baidal, Camillo Ricordi, Rodolfo Alejandro. Combined liver and islet transplantation in hepatogenous diabetes, cluster exenteration, and cirrhosis with type 1 diabetes. Chapter 37 in: Orlando G, Piemonti L, Ricordi C, Stratta RJ, and Gruessner RWG, (eds). Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas, 1st Edition, Volume 1. San Diego: Elsevier Inc./Academic Press, 2020: 439-453. DOI: 10.1016/B978-0-12-814833-4.00037-X. ISBN: 9780128148334.
  6. David A. Baidal, Marco Infante, Virginia Fuenmayor, Ana M. Alvarez, Nathalia Padilla, Dora M. Berman, Antonello Pileggi, Elina Linetsky, Gaetano Ciancio, Camillo Ricordi, Rodolfo Alejandro. A biologic resorbable scaffold for tissue engineering of the endocrine pancreas: Clinical experience of islet transplantation on the omentum. Chapter 19 in: Orlando G, Piemonti L, Ricordi C, Stratta RJ, and Gruessner RWG, (eds). Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas, 1st Edition, Volume 2. San Diego: Elsevier Inc./Academic Press, 2020: 269-276. DOI: 10.1016/B978-0-12-814831-0.00019-1. ISBN: 9780128148310.
  7. Marco Infante, Massimiliano Caprio, Andrea Fabbri (2020). Introduction: Causes and Risk Factors for Male Osteoporosis. Chapter 5 in: Ferlin A., Migliaccio S. (eds) Male Osteoporosis. Trends in Andrology and Sexual Medicine. Springer, Cham. DOI: 10.1007/978-3-319-96376-1_5. ISBN: 978-3-319-96375-4.  
  8. Marco Infante, Rodolfo Alejandro, Andrea Fabbri, Camillo Ricordi. The heterogeneity of type 1 diabetes: From immunopathology to immune intervention. Chapter 5 in: Translational Autoimmunity (Elsevier), 1st Edition, Volume 4 (Autoimmune Diseases in Different Organs), pages 83-104; May 1, 2022 (Editor: Nima Rezaei). DOI: 10.1016/B978-0-12-824466-1.00001-7. ISBN: 9780128244661.
  9. Marco Infante. The Insulin Journey in the Human Body. Chapter 1 in: Evolving Concepts in Insulin Resistance (IntechOpen publisher), December 7, 2022 (Academic Editor: Marco Infante). DOI: 10.5772/intechopen.107906. ISBN: 9781803555027. PRINT ISBN: 9781803555010. EBOOK (PDF): ISBN 9781803555034. 
  10. Martina Leoni, Nathalia Padilla, Andrea Fabbri, David Della-Morte, Camillo Ricordi and Marco Infante. Mechanisms of Insulin Resistance during Pregnancy. Chapter 4 in: Evolving Concepts in Insulin Resistance (IntechOpen publisher), December 7, 2022 (Academic Editor: Marco Infante). DOI: 10.5772/intechopen.107907. ISBN: 9781803555027. PRINT ISBN: 9781803555010. EBOOK (PDF): ISBN 9781803555034. 

 

Libri e Volumi Pubblicati

  1. Evolving Concepts in Insulin Resistance (IntechOpen publisher), December 7, 2022 (Academic Editor: Marco Infante). DOI: 10.5772/intechopen.98058. ISBN: 9781803555027. PRINT ISBN: 9781803555010. EBOOK (PDF): ISBN 9781803555034.   

 

Technical Reports

  1. Marco Infante, Andrea Fabbri, Camillo Ricordi. Towards a sustainable prevention of type 2 diabetes. Europe and Food Report 2021, Barilla Center for Food & Nutrition Foundation (BCFN, May 2021, pp. 44-47; URL: www.fondazionebarilla.com/wp-content/uploads/2021/02/europe-and-food.pdf).

 

Pubblicazioni su Riviste Scientifiche Nazionali “Peer-Reviewed”

  1. Caprio M, Infante M, Armani A, Lenzi A, Fabbri A. Recettore mineralcorticoide e organo adiposo: implicazioni cliniche e terapeutiche. L’Endocrinologo (2016) 17:73. DOI: 10.1007/s40619-016-0179-9.
  2. Fabbri A, Infante M, Petrelli M, Arnaldi G.  Anoressia nervosa e salute dell’osso. L’Endocrinologo (2017) 18: 2. DOI: 10.1007/s40619-017-0262-x.
  3. Infante M, Fabbri A. Effetti della co-supplementazione di vitamina D e acidi grassi omega-3 sul controllo glicemico e le concentrazioni lipidiche nelle pazienti affette da diabete mellito gestazionale. L’Endocrinologo (2017) 18:197. DOI: 10.1007/s40619-017-0335-x.
  4. Infante M, Fabbri A. Le cellule iNKT inducono l’espressione di FGF21 per la termogenesi e sono essenziali per ottenere la massima perdita di peso in corso di trattamento con analoghi del GLP-1. L’Endocrinologo (2017) 18: 308. DOI: 10.1007/s40619-017-0370-7.
  5. Infante M, Fabbri A. Gli acidi grassi polinsaturi omega-3 migliorano il diabete di tipo 1 e l’autoimmunità. L’Endocrinologo (2018) 19:114. DOI: 10.1007/s40619-018-0427-2.
  6. Piantoni L, Infante M, Passeri M, Fabbri A. La sfida della diagnosi precoce nel paziente acromegalico. Acrocare (2018); Volume 2, Numero 1, Maggio 2018, pp. 19-23.
  7. Infante M, Fabbri A. Concentrazioni plasmatiche di 25-idrossivitamina D e rischio di diabete di tipo 2 e pre-diabete: uno studio di coorte di 12 anni. L’Endocrinologo (2018) 19:223. DOI: 10.1007/s40619-018-0461-0.
  8. Infante M, Fabbri A. La liraglutide aumenta i tassi di gravidanza dopo IVF in donne obese con PCOS e scarsa risposta alle terapie di prima linea: uno studio pilota randomizzato. L’Endocrinologo (2018) 19:331. DOI: 10.1007/s40619-018-00503-y.
  9. Infante M, Fabbri A. Supplementazione di vitamina D e prevenzione di cancro e malattie cardiovascolari. L’Endocrinologo (2019) 20:113. DOI: 10.1007/s40619-019-00566-5.
  10. Moriconi E, Infante M, Gorini S, Fabbri A, Caprio M. Come avviare il paziente obeso alla terapia chetogenica. L’Endocrinologo (2019) 20:196. DOI: 10.1007/s40619-019-00602-4.
  11. Infante M, Fabbri A. Supplementazione di vitamina D e prevenzione del diabete di tipo 2. L’Endocrinologo (2019) 20:250. DOI: 10.1007/s40619-019-00610-4.
  12. Infante M, Di Perna P, Fabbri A. Risultati a 10 anni del trapianto di isole pancreatiche isolato o dopo trapianto renale nel diabete di tipo 1: uno studio di coorte prospettico a gruppi paralleli. L’Endocrinologo 21, 60–61 (2020). DOI: 10.1007/s40619-020-00664-9.
  13. Infante M, Fabbri A. Impatto della sequenza temporale di ingestione degli alimenti sulle escursioni glicemiche post-prandiali nel prediabete. L’Endocrinologo 21, 68–69 (2020). DOI: 10.1007/s40619-020-00662-x.
  14. Infante M, Velikova T, Fabbri A. Vitamin D and anti-COVID-19 vaccination [Vitamina D e vaccinazione anti-COVID-19]. LRIOG – La Rivista Italiana di Ostetrica e Ginecologia. Volume 2021, Issue 4 (1 Dicembre 2021): 51-59. p-ISSN: 1724-6776. e-ISSN: 1824-0283. DOI: 10.53146/lriog1202148.
  15. Leoni M*, Infante M*, Infante R, Caprio M, Fabbri A. Hypovitaminosis D and metabolic syndrome [Ipovitaminosi D e sindrome metabolica]. LRIOG – La Rivista Italiana di Ostetrica e Ginecologia. Volume 2022, Issue 1 (1 Marzo 2022): 95-106. p-ISSN: 1724-6776. e-ISSN: 1824-0283. DOI: 10.53146/lriog1202162. *Equal contribution to the manuscript.